Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mymd Pharmaceuticals, Inc. (AKER) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mymd Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1321834.
Total stock buying since 2014: $976,467.
Total stock sales since 2014: $81,368.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 175,000 | $194,575 | 0 | $0 | 0 | $0 |
| 2022 | 10,000 | $15,300 | 0 | $0 | 0 | $0 |
| 2021 | 30,000 | $195,180 | 0 | $0 | 394,680 | $0 |
| 2020 | 0 | $0 | 28,938 | $81,368 | 15,603 | $0 |
| 2019 | 184,578 | $554,580 | 0 | $0 | 0 | $0 |
| 2016 | 4,600 | $8,369 | 0 | $0 | 0 | $0 |
| 2015 | 3,500 | $5,250 | 0 | $0 | 0 | $0 |
| 2014 | 1,020 | $3,213 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 175,000 | $194,575 | 0 | $0 | 0 | $0 |
| 2022-12 | 10,000 | $15,300 | 0 | $0 | 0 | $0 |
| 2021-11 | 30,000 | $195,180 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 394,680 | $0 |
| 2020-02 | 0 | $0 | 28,938 | $81,368 | 0 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 15,603 | $0 |
| 2019-12 | 184,578 | $554,580 | 0 | $0 | 0 | $0 |
| 2016-05 | 2,500 | $5,555 | 0 | $0 | 0 | $0 |
| 2016-01 | 2,100 | $2,814 | 0 | $0 | 0 | $0 |
| 2015-12 | 3,500 | $5,250 | 0 | $0 | 0 | $0 |
| 2014-08 | 1,020 | $3,213 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-24 | Rivard Paul (Chief Legal Officer) | Buy | 150,000 | 1.11 | 166,500 |
| 2023-08-17 | Rivard Paul (Chief Legal Officer) | Buy | 25,000 | 1.12 | 28,075 |
| 2022-12-08 | Rivard Paul (EVP of Operations, GC) | Buy | 10,000 | 1.53 | 15,300 |
| 2021-11-26 | Silverman Joshua | Buy | 5,000 | 7.55 | 37,770 |
| 2021-11-24 | Silverman Joshua | Buy | 10,000 | 6.70 | 66,960 |
| 2021-11-23 | Rivard Paul (EVP of Operations, GC) | Buy | 15,000 | 6.03 | 90,450 |
| 2021-04-16 | Schreiber Christopher C | Option Ex | 131,750 | .00 | 0 |
| 2021-04-16 | White Billy Joe | Option Ex | 109,500 | .00 | 0 |
| 2021-04-16 | Silverman Joshua | Option Ex | 109,500 | .00 | 0 |
| 2021-04-16 | Schroeder Robert C | Option Ex | 43,930 | .00 | 0 |
| 2020-02-28 | Gerber Sander (10% Owner) | Sale | 638 | 2.81 | 1,792 |
| 2020-02-27 | Gerber Sander (10% Owner) | Sale | 15,300 | 2.72 | 41,616 |
| 2020-02-25 | Gerber Sander (10% Owner) | Sale | 13,000 | 2.92 | 37,960 |
| 2020-01-01 | Schreiber Christopher C (Executive Chairman) | Option Ex | 5,201 | .00 | 0 |
| 2020-01-01 | White Billy Joe | Option Ex | 5,201 | .00 | 0 |
| 2020-01-01 | Silverman Joshua | Option Ex | 5,201 | .00 | 0 |
| 2019-12-20 | Gerber Sander (10% Owner) | Buy | 8,000 | 3.02 | 24,160 |
| 2019-12-19 | Gerber Sander (10% Owner) | Buy | 2,700 | 3.08 | 8,316 |
| 2019-12-18 | Gerber Sander (10% Owner) | Buy | 7,500 | 3.07 | 23,025 |
| 2019-12-17 | Gerber Sander (10% Owner) | Buy | 3,000 | 3.03 | 9,090 |
| 2019-12-16 | Gerber Sander (10% Owner) | Buy | 5,000 | 3.07 | 15,350 |
| 2019-12-13 | Gerber Sander (10% Owner) | Buy | 6,000 | 3.02 | 18,120 |
| 2019-12-12 | Gerber Sander (10% Owner) | Buy | 20,600 | 2.98 | 61,388 |
| 2019-12-11 | Gerber Sander (10% Owner) | Buy | 32,425 | 3.08 | 99,706 |
| 2019-12-10 | Gerber Sander (10% Owner) | Buy | 30,000 | 2.97 | 89,100 |
| 2019-12-09 | Gerber Sander (10% Owner) | Buy | 69,353 | 2.98 | 206,325 |
| 2016-05-24 | Gormally John J (Chief Executive Officer) | Buy | 2,500 | 2.22 | 5,555 |
| 2016-01-05 | Akers Raymond Francis Jr (Executive Chairman, Secretary) | Buy | 2,100 | 1.34 | 2,814 |
| 2015-12-11 | Rauch Gary M (VP - Finance, Treasurer) | Buy | 3,500 | 1.50 | 5,250 |
| 2014-08-22 | Rauch Gary M (VP of Finance, Treasurer) | Buy | 1,020 | 3.15 | 3,213 |
Insider trading activities including stock purchases, stock sales, and option exercises of AKER listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mymd Pharmaceuticals, Inc. (symbol AKER, CIK number 1321834) see the Securities and Exchange Commission (SEC) website.